EF
ASND icon

Empowered Funds’s Ascendis Pharma A/S ASND Stock Holding History

Empowered Funds’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.9M Buy
187,271
+136,136
+266% +$31.8M 0.26% 71
2026
Q1 		$11.7M Buy
51,135
+14,438
+39% +$3.24M 0.07% 321
2025
Q4 		$7.83M Buy
36,697
+620
+2% +$128K 0.13% 179
2025
Q3 		$7.17M Buy
36,077
+2,881
+9% +$537K 0.07% 369
2025
Q2 		$5.73M Buy
+33,196
New +$5.41M 0.06% 399

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Empowered Funds's ASND Position: Q2 2026 in Review

Empowered Funds increased its Ascendis Pharma A/S (ASND) stake by 266% in Q2 2026, buying an estimated $31.8M and bringing the position to 187,271 shares worth $49.9M. The position accounts for 0.26% of the portfolio, ranked #71.

Empowered Funds first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Empowered Funds held 187,271 shares of Ascendis Pharma A/S worth $49.9M as of Q2 2026.
  • Empowered Funds bought 136,136 Ascendis Pharma A/S shares in Q2 2026, an estimated $31.8M.
  • Ascendis Pharma A/S made up 0.26% of Empowered Funds's portfolio in Q2 2026, its #71 holding.
  • Empowered Funds first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.